Valuation (83%) |
Company | Industry |
|---|---|---|
| P/E Ratio (TTM) | 0.26 | 8.51 |
| PEG Ratio (TTM) | 0.00 | -8.52 |
| P/S Ratio (TTM) | 0.01 | 0.51 |
| P/B Ratio (TTM) | 0.03 | 1.40 |
| P/FCF Ratio (TTM) | 0.54 | 13.67 |
| Price to 5YR AVG Earnings Ratio | N/A | 13.61 |
| Price to 5YR AVG FCF Ratio | 0.40 | 65.18 |
Profitability (55%) |
Company | Industry |
|---|---|---|
| ROA (TTM) | 6.64% | 4.50% |
| ROE (TTM) | 11.46% | 5.11% |
| Net Profit Margin (TTM) | 3.10% | 0.50% |
| ROIC 5YR AVG | 12.12% | 11.53% |
Growth (75%) |
4QTR AVG | 3YR AVG | 5YR AVG |
|---|---|---|---|
| EPS | -25.00% | -66.67% | -60.00% |
| Revenue | 411.66% | 1,749.69% | 1,436.38% |
| Net Income | 109.77% | 1,231.48% | 1,017.94% |
| Cash Flow | 1,071.14% | 1,263.93% | 1,126.49% |
Health (67%) |
Company | Industry |
|---|---|---|
| Current Ratio (TTM) | 1.62 | 1.94 |
| Quick Ratio (TTM) | 0.99 | 1.15 |
| D/E Ratio (TTM) | 0.20 | 0.53 |
| Interest Coverage (TTM) | 7.75 | 5.51 |
| Piotroski F-Score | 7 | 6 |
| Altman Z-Score | 2.35 | 3.73 |
| LTL to 5YR AVG FCF | 2.18 | 16.95 |
| Shares Outstanding Growth 5YR AVG | -60.00% | -6.98% |